Jennifer Solano
Medical · Scottsdale, AZNPI 1619305349
Payments from drug & device makers
Across 325 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Lilly USA, LLC$500
- GSK$311
- Pfizer$184
- Exact Sciences$167
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,703100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 122 | $1,866 |
| AstraZeneca | 49 | $1,027 |
| Lilly USA, LLC | 36 | $500 |
| GSK | 18 | $311 |
| Pfizer | 11 | $184 |
| Exact Sciences | 8 | $167 |
| Novo Nordisk | 10 | $167 |
| Lucid Diagnostics Inc. | 5 | $160 |
| Abbott | 7 | $156 |
| Boehringer Ingelheim | 7 | $134 |
| Phathom Pharmaceuticals, Inc. | 5 | $116 |
| Eisai Inc. | 5 | $114 |
| Impel Pharmaceuticals Inc. | 4 | $90 |
| Amgen | 5 | $79 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Johnson & Johnson | 2 | $63 |
| Clarus Therapeutics Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Biohaven Pharmaceuticals, Inc. | 2 | $54 |
| Nestle Healthcare Nutrition Inc. | 2 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| IBSA Pharma Inc. | 2 | $39 |
| Merck | 2 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Vistapharm, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,703 in reported general payments places this provider in the 85th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 27 | $31,671 |
| FarxigaDapagliflozin Propanediol | 20 | $13,733 |
| TrulicityDulaglutide | 11 | $12,355 |
| RybelsusSemaglutide | 12 | $11,309 |
| Gabapentin | 12 | $755 |
| Zolpidem Tartrate | 29 | $490 |
| Levothyroxine Sodium | 46 | $425 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $413 |
| Lisinopril | 44 | $397 |
| ValacyclovirValacyclovir Hcl | 11 | $338 |
| Atorvastatin Calcium | 47 | $299 |
| Sertraline Hcl | 16 | $262 |
| Hydroxyzine Hcl | 20 | $241 |
| Valsartan | 23 | $236 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $500 | $44,02638 claims |
| AstraZenecaFarxiga | $1,027 | $13,73320 claims |
| Novo NordiskRybelsus | $167 | $11,30912 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $28 | $42546 claims |
| PfizerPaxlovid | $184 | $014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 748 medical providers in Arizona.
Other medical in Scottsdale
- Robert CasquejoScottsdale$474K
- Darren WestScottsdale$206K
- Jamie WystrachScottsdale$79K
- Kendall JensonScottsdale$39K
- Ann Marie ChavezScottsdale$23K
- Emma ReeveScottsdale$15K
- Fiona BluntScottsdale$12K
- Francine MartynScottsdale$10K
- Victoria CarpenterScottsdale$9K
- Andrew HicksPeoria$460K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.